CVS Health reports Q3 results, raises 2026 guidance

CVS Health Raises 2026 EPS Guidance to at Least $6.98 from Prior View $6.84-$7.04 >CVS

CVS Health Raises 2026 Adjusted EPS Guidance to at Least $8.20 from Prior View $7.90-$8.10 >CVS

CVS Health Raises 2026 Cash Flow from Operations Guidance to at Least $15.5B from at Least $11.5B >CVS

By Freddy SebastianCVS Health raised its full-year guidance on gains in its health-care benefits and pharmacy segments, but said it remains cautious amid high costs and potential macroeconomic headwinds.The outlook comes after the company said Tuesday that it plans to split in two, with one company…

Third quarter total revenues increased to $108.4 billion, up 5.4% year-over-year Third quarter GAAP

CVS Health reported Q3 adjusted EPS of $2.09, up from $1.60 a year earlier, and raised full-year 2026 GAAP EPS, adjusted EPS and operating cash flow guidance. GAAP diluted EPS was $1.68 versus a $3.13 loss, partly reflecting the absence of a prior-year $5.7B goodwill impairment charge.Material Deta…